Hennessy Advisors Inc. Boosts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Hennessy Advisors Inc. boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 550.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,188,400 shares of the company’s stock after acquiring an additional 3,544,300 shares during the quarter. Oscar Health accounts for approximately 1.7% of Hennessy Advisors Inc.’s investment portfolio, making the stock its 14th biggest position. Hennessy Advisors Inc. owned 1.69% of Oscar Health worth $56,292,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of OSCR. Victory Capital Management Inc. lifted its position in shares of Oscar Health by 114.1% during the second quarter. Victory Capital Management Inc. now owns 40,976 shares of the company’s stock worth $648,000 after purchasing an additional 21,840 shares in the last quarter. Amalgamated Bank lifted its holdings in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Oscar Health by 42.3% in the second quarter. XTX Topco Ltd now owns 66,930 shares of the company’s stock worth $1,059,000 after acquiring an additional 19,886 shares in the last quarter. Public Employees Retirement Association of Colorado purchased a new stake in shares of Oscar Health during the second quarter worth $229,000. Finally, Sei Investments Co. raised its stake in shares of Oscar Health by 260.5% in the second quarter. Sei Investments Co. now owns 155,010 shares of the company’s stock valued at $2,452,000 after acquiring an additional 112,012 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the transaction, the insider now owns 81,962 shares in the company, valued at $1,481,872.96. The trade was a 7.36 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the sale, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $14.94 on Friday. The firm has a market capitalization of $3.69 billion, a P/E ratio of -248.88, a P/E/G ratio of 0.57 and a beta of 1.70. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.45 and a 52 week high of $23.79. The firm’s 50 day moving average is $14.98 and its two-hundred day moving average is $16.83.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same quarter in the prior year, the business earned ($0.29) earnings per share. Oscar Health’s revenue was up 68.3% compared to the same quarter last year. Research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Analysts Set New Price Targets

OSCR has been the subject of several analyst reports. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. Jefferies Financial Group began coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price on the stock. Finally, Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $21.56.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.